BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents. 2023

Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic address: chenjichao@njucm.edu.cn.

A series of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine were designed and synthesized with improved anti-hepatocellular carcinoma (HCC) activities. The optimal compound 4d showed strong activities against HepG2, Sk-Hep-1, Huh-7 and Hep3B cells with IC50 values of 0.58-1.15 μM, which were superior to positive reference cisplatin. Interestingly, 4d exhibited over 40-fold more potent activity against cisplatin-resistant HepG2/DPP cells while showing lower cytotoxicity in normal LX-2 cells. The mechanism studies revealed 4d greatly stabilized G-quadruplex DNA leading to intracellular c-MYC expression downregulation, blocked G2/M-phase cell cycle by affecting related p-cdc25c, cdc2 and cyclin B1 expressions, and induced apoptosis by a ROS-promoted PI3K/Akt-mitochondrial pathway. Furthermore, 4d possessed good pharmacokinetic properties and significantly inhibited the tumor growth in the H22 liver cancer xenograft mouse model without obvious toxicity. Altogether, the remarkably biological profiles of 4d both in vitro and in vivo would make it a promising candidate for HCC therapy.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008516 Medicine, Chinese Traditional A system of traditional medicine which is based on the beliefs and practices of the Chinese culture. Chinese Medicine, Traditional,Chung I Hsueh,Traditional Medicine, Chinese,Zhong Yi Xue,Chinese Traditional Medicine,Traditional Chinese Medicine,Traditional Tongue Assessment,Traditional Tongue Diagnosis,Hsueh, Chung I,Tongue Assessment, Traditional,Tongue Diagnoses, Traditional,Tongue Diagnosis, Traditional,Traditional Tongue Assessments,Traditional Tongue Diagnoses
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents.
June 2018, Bioorganic & medicinal chemistry letters,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellular carcinoma agents.
January 2012, Bioorganic & medicinal chemistry letters,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.
August 2016, Bioorganic & medicinal chemistry letters,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents.
February 2022, Bioorganic & medicinal chemistry,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
September 2018, Molecules (Basel, Switzerland),
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents.
February 2020, RSC advances,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
N-Substituted Aryl Sulphonamides as Potential Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
January 2018, Current computer-aided drug design,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents.
January 2019, Frontiers in chemistry,
Jichao Chen, and Yiping Duan, and Kan Yang, and Jiahe Wang, and Junjie Yan, and Chenglei Gu, and Shanglong Wang, and Zheying Zhu, and E-Hu Liu, and Jinyi Xu
Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents.
January 2016, Anti-cancer agents in medicinal chemistry,
Copied contents to your clipboard!